Viewing Study NCT00720408

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:56 AM
Ignite Modification Date: 2026-06-25 @ 3:46 AM
Study NCT ID: NCT00720408
Status: COMPLETED
Last Update Posted: 2009-09-15
First Post: 2008-07-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Liver Transplantation View
None Transplantation Immunology View
None Host vs Graft Reaction View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunosuppressant View
None Graft loss View
None Combination drug therapy View
None Randomized controlled trial View
None Open level method View